Home › Funds › Vestal Point Capital, LP › ANRO

Vestal Point Capital, LP position in ANRO

ALTO NEUROSCIENCE INC COM SHS · Health Care

Vestal Point Capital, LP reported holding 785,000 shares of ANRO (ALTO NEUROSCIENCE INC COM SHS) in its Q2 2026 13F filing — a position valued at US$20.7M, representing 0.48% of its reported portfolio and ranking #43 among its reported holdings. Vestal Point Capital, LP has disclosed ANRO holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)785.00K sh
Reported value held$20.72M
Portfolio Weight0.48%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's ANRO position evolved

Vestal Point Capital, LP first disclosed a stake in ANRO in Q1 2024 at 250,000 shares (US$3.8M). The position peaked in Q1 2026 at 2,064,075 shares, worth US$46.4M. Across 10 filings, Vestal Point Capital, LP increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 785,000 shares valued at US$20.7M — a reduction of -1,279,075 shares quarter over quarter.. Notable position changes include a 148% increase in Q2 2024 (shares rose 7% over the following quarter), a 162% increase in Q4 2025 (shares rose 26% over the following quarter), a 62% trim in Q2 2026 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 250.00K $3.84M New
Q2 2024 620.00K $6.63M Add
Q3 2024 650.00K $7.44M Add
Q4 2024 915.00K $3.87M Add
Q1 2025 915.00K $1.98M Hold
Q2 2025 950.00K $2.09M Add
Q3 2025 950.00K $3.82M Hold
Q4 2025 2.48M $44.23M Add
Q1 2026 2.06M $46.40M Reduce
Q2 2026 785.00K $20.72M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANRO and 13F data

ANRO (ALTO NEUROSCIENCE INC COM SHS) is a Health Care company. 58 other funds we track also report a position in ANRO — the largest reported positions include Alpha Wave Global, LP (US$97.8M), Commodore Capital LP (US$71.9M), PERCEPTIVE ADVISORS LLC (US$42.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANRO

All ANRO fund holders →

FAQ

How long has Vestal Point Capital, LP held ANRO?

Vestal Point Capital, LP has disclosed ANRO holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is Vestal Point Capital, LP's current position in ANRO?

As of Q2 2026, Vestal Point Capital, LP holds 785.00K shares of ANRO (ALTO NEUROSCIENCE INC COM SHS), valued at $20.72M, representing 0.48% of its reported portfolio and ranking #43.

Has Vestal Point Capital, LP been buying or selling ANRO?

In the latest 13F filing (Q2 2026), Vestal Point Capital, LP reduced its position in ANRO. The position peaked in Q1 2026 at 2.06M shares.

Which other funds hold ANRO?

Other major institutional holders of ANRO include Alpha Wave Global, LP, Commodore Capital LP, PERCEPTIVE ADVISORS LLC, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.